flavon
ingredi
prescript
antiviru
highest
viru
inhibitori
rate
mortal
morbid
protect
rate
b
r
c
order
screen
better
flavon
prescript
antinewcastl
diseas
viru
ndv
four
flavon
ingredi
epimedium
flavon
ef
baikal
skullcap
root
flavon
bsrf
wild
dendranthema
flower
flavon
wdff
sanchi
flavon
sf
screen
previou
experi
prescript
ad
chicken
embryo
fibroblast
monolay
three
drugad
mode
respect
cellular
valu
highest
viru
inhibitori
rate
score
base
viru
inhibitori
rate
calcul
compar
antivir
activ
immun
protect
test
effect
three
prepar
efbsrf
efsfwdffbsrf
efwdffbsrf
screen
result
vitro
experi
ndv
infect
compar
chicken
vaccin
nd
vaccin
challeng
ndv
blood
regularli
sampl
serum
antibodi
titer
determin
pathogen
dead
status
chicken
clinic
examin
result
indic
valu
nine
prescript
especi
foresaid
three
prescript
almost
concentr
three
drugad
mode
significantli
higher
viru
control
group
foresaid
three
prescript
present
top
five
highest
viru
inhibitori
rate
locat
highest
three
score
rank
antibodi
titer
protect
rate
three
prescript
group
higher
vc
group
especi
efsfwdffbsrf
group
show
signific
differ
result
indic
flavon
prescript
compos
suitabl
compat
could
possess
synergist
action
antivir
effect
essfwdffbsrf
prescript
could
inhibit
cellular
infect
ndv
improv
protect
effect
nd
vaccin
would
expect
exploit
newtyp
antivir
drug
past
year
anim
infecti
diseas
especi
viral
diseas
cow
transmiss
spongiform
encephalopathi
sever
acut
respiratori
syndrom
swine
hyperpyrexia
diseas
untyp
classic
swine
fever
newcastl
diseas
nd
worldwid
concern
emerg
continu
take
stage
comeback
spread
quickli
usual
caus
great
loss
domest
anim
poultri
industri
viru
uniqu
biolog
characterist
pathogenesi
effect
treatment
method
viral
diseas
viru
diseas
becom
one
seriou
threaten
human
anim
health
vaccin
common
prevent
method
infecti
diseas
still
difficult
control
efficaci
vaccin
sever
decreas
viru
circul
good
match
vaccin
strain
due
antigen
drift
inaccur
epidemiolog
predict
vaccin
inferior
qualiti
improp
conserv
transport
problem
chemic
drug
use
clinic
effect
satisfi
obviou
neg
effect
drug
residu
drug
toler
high
recurr
rate
environment
pollut
therefor
becom
urgent
studi
develop
newtyp
antivir
drug
high
effici
low
toxic
import
topic
mani
scholar
recent
year
prove
mani
chines
herbal
medicin
chm
ingredi
chmi
possess
antivir
effect
chm
extract
astragalu
polysaccharid
inject
extract
indigowoad
root
develop
antibacteri
antivir
agent
one
hand
chm
possess
mani
biolog
activ
adjust
immunolog
function
inhibit
viral
process
adsorpt
transcript
replic
releas
show
reliabl
biolog
function
littl
side
effect
low
toxic
hand
mani
research
demonstr
chm
possess
mani
antivir
activ
materi
mani
activ
materi
discov
yet
moreov
new
viru
strain
viru
emerg
continu
antivir
compound
screen
chm
becam
hotspot
mani
investig
newcastl
diseas
kind
violent
infecti
diseas
caus
newcastl
diseas
viru
ndv
usual
caus
great
loss
poultri
industri
control
diseas
mainli
vaccin
nd
vaccin
although
strict
immun
program
taken
farm
diseas
still
hard
control
though
chines
veterinari
herbal
medic
prepar
inject
honeysuckl
flowerba
skullcap
rootforsythia
suspens
inject
astragalu
polysaccharid
becom
one
princip
weapon
veterinari
clinic
therapi
play
import
role
clinic
epidem
prevent
prepar
display
satisfactori
clinic
effect
diseas
research
develop
effect
clinic
medicin
still
one
primari
task
mani
veterinari
worker
pharmacolog
effect
chm
base
chemic
constitu
flavon
one
import
activ
ingredi
enhanc
immun
function
organ
inhibit
viru
infect
previou
research
confirm
epimedium
flavon
ef
baical
skullcap
root
flavon
bsrf
wild
dendranthema
flower
flavon
wdff
sanchi
flavon
sf
could
significantli
inhibit
cellular
infect
ndv
chicken
embryo
fibroblast
cef
present
experi
antivir
effect
nine
flavon
ingredi
prescript
base
abovement
four
flavon
ingredi
compar
determin
effect
cellular
infect
ndv
better
prescript
chosen
protect
effect
nd
artifici
challeng
observ
purpos
experi
observ
antivir
action
flavon
ingredi
prescript
search
optim
combin
flavon
ingredi
select
best
prescript
offer
theoret
evid
develop
newtyp
antivir
drug
eagl
minimum
essenti
medium
mem
gibco
supplement
penicillin
iuml
streptomycin
iuml
fetal
bovin
serum
call
growth
medium
use
cultur
cell
fetal
bovin
serum
mainten
medium
mm
dilut
flavon
ingredi
maintain
cell
hank
solut
use
wash
chick
embryo
tissu
shiver
bromid
mtt
amresco
co
dissolv
mgml
calcium
magnesiumfre
cmf
phosphatebuff
salin
pb
ph
trypsin
dissolv
cmfpb
ph
dimethyl
sulfoxid
dmso
produc
zhengx
institut
chemic
engin
suzhou
china
reagent
filter
syring
filter
mem
mm
store
c
mtt
solut
c
dark
bottl
chemic
use
experi
analyt
grade
epimedium
flavon
ef
net
content
baical
skullcap
root
flavon
bsrf
net
content
wild
dendranthema
flower
flavon
wdff
net
content
sanchi
flavon
sf
net
content
extract
refin
macropor
resin
laboratori
concentr
flavon
ingredi
prescript
maxim
safe
concentr
cef
gml
test
vitro
four
singl
flavon
ingredi
nine
flavon
ingredi
prescript
dilut
four
concentr
gml
twofold
serial
dilut
mm
steril
store
c
accord
result
test
vitro
three
ingredi
prescript
efbsrf
efsfwdffbsrf
efwdffbsrf
screen
test
vivo
three
ingredi
prescript
dilut
mgml
net
content
cmfpb
test
vivo
endotoxin
amount
standard
chines
veterinari
pharmacopoeia
cef
prepar
specif
pathogen
free
chicken
embryo
nanj
pharmaceut
apparatu
factori
china
anim
husbandri
industri
compani
brief
eggshel
disinfect
open
chick
embryo
taken
remov
head
extrem
viscera
wash
hank
solut
cut
mm
piec
wash
three
time
hank
solut
trypsogen
solut
ad
trypsin
min
c
centrifug
precipit
wash
three
time
hank
solut
filter
gauz
cell
count
dilut
ml
mem
inocul
cultur
plate
h
c
humid
atmospher
co
cef
grew
monolay
mem
remov
cef
monolay
wash
calcium
magnesiumfre
phosphatebuff
salin
cmfpb
ph
taken
standbi
cmfpb
remov
nd
vaccin
mukteswar
strain
purchas
beij
veterinari
biodrug
compani
tcid
viru
liquid
reedmueech
assay
dilut
tcid
mm
use
antivir
assay
nd
viru
ndv
f
e
strain
use
challeng
experi
suppli
china
institut
veterinari
drug
control
propag
specif
pathogenfre
chicken
embryo
titer
ndv
f
e
strain
stock
solut
reedmueech
assay
cef
prepar
abovement
method
cef
grew
monolay
serial
twofold
dilut
four
singl
flavon
ingredi
nine
flavon
ingredi
prescript
ndv
mukteswar
strain
tcid
ad
three
samplead
mode
respect
simultaneousad
drug
viru
mix
four
singl
flavon
ingredi
nine
flavon
ingredi
prescript
solut
differ
concentr
gml
mix
equalvolum
ndv
solut
respect
incub
h
c
ad
cef
plate
l
per
well
four
well
per
concentr
pread
drug
four
singl
flavon
ingredi
nine
flavon
ingredi
prescript
solut
differ
concentr
ad
cef
plate
first
l
per
well
four
well
per
concentr
incub
h
c
viru
solut
ad
l
per
well
postad
drug
viru
solut
ad
cef
plate
first
l
per
well
plate
incub
co
incub
c
h
four
singl
flavon
ingredi
nine
flavon
ingredi
prescript
solut
differ
concentr
ad
cef
plate
l
per
well
four
well
per
concentr
simultan
viru
control
group
ad
ndv
cell
control
group
ad
mm
blank
group
cell
design
group
keep
c
co
incub
ndv
control
group
appear
obvious
cytopath
effect
h
cef
living
measur
mtt
colorimetr
assay
l
mtt
ad
well
reincub
anoth
h
plate
centrifug
g
min
room
temperatur
supernat
remov
care
l
dmso
ad
well
dissolv
formazan
crystal
plate
shaken
min
dissolv
crystal
complet
cellular
optic
absorb
wave
length
nm
valu
well
measur
microlit
enzymelink
immunosorb
assay
reader
model
leidu
bioscienc
corpor
shenzhen
citi
viru
inhibitori
rate
calcul
base
formula
viru
inhibitori
rate
drugviru
viru
control
cell
control
viru
control
order
compar
antivir
activ
among
differ
ingredi
easili
especi
signal
flavon
prescript
score
base
viru
inhibitori
rate
analyz
drug
highest
viru
inhibitori
rate
score
kind
drug
next
analog
one
one
lowest
score
score
rank
valu
viru
inhibitori
rate
score
consid
indic
antivir
activ
onedayold
white
roman
chicken
male
purchas
tangquan
poultri
farm
hous
wire
cage
cm
cm
aircondit
room
c
light
h
begin
pretrial
period
temperatur
gradual
declin
room
temperatur
light
time
h
per
day
kept
constant
follow
day
chicken
fed
commerci
starter
diet
provid
feed
factori
jiangsu
academi
agricultur
scienc
two
hundr
fifti
chicken
randomli
divid
five
group
vaccin
newcastl
diseas
vaccin
except
blank
control
bc
group
revaccin
day
age
h
vaccin
chicken
three
flavon
prescript
group
efbsrf
efsfwdffbsrf
efwdffbsrf
screen
accord
result
antivir
assay
experi
treat
aqueou
efbsrf
efsfwdffbsrf
efwdffbsrf
solut
dosag
mg
per
feather
day
three
day
respect
vaccin
control
vc
bc
group
replac
volum
cmfpb
day
three
day
day
first
vaccin
chicken
except
bc
group
challeng
ml
ndv
intramuscular
inject
vaccin
day
first
vaccin
day
challeng
blood
sampl
determin
serum
hemagglutin
inhibit
hi
antibodi
titer
pathogen
dead
status
chicken
clinic
examin
daili
success
day
challeng
mortal
morbid
protect
rate
everi
group
calcul
accord
formula
mortal
number
dead
chicken
number
sampl
morbid
number
chicken
dead
show
clinic
symptom
number
sampl
protect
rate
number
chicken
without
clinic
symptom
experimentth
number
sampl
one
millilit
blood
sampl
per
chick
collect
brachial
vein
put
ml
eppendorf
tube
allow
clot
c
h
serum
separ
store
c
hi
antibodi
assay
briefli
inactiv
complement
c
min
twofold
serial
dilut
made
dilut
rang
vshape
bottom
microtit
plate
contain
l
cmfpb
well
l
ndv
antigen
ha
unit
ad
well
except
last
row
control
antigen
serum
mixtur
incub
min
c
l
rooster
erythrocyt
suspens
ad
well
continu
incub
min
immun
posit
serum
neg
serum
erythrocyt
antigen
also
includ
control
highest
dilut
serum
caus
complet
inhibit
consid
endpoint
geometr
mean
titer
express
reciproc
valu
highest
dilut
display
hi
data
valu
antibodi
titer
express
mean
sd
duncan
multipl
rang
test
use
analyz
differ
among
group
softwar
spss
x
test
use
analyz
differ
mortal
morbid
protect
rate
signific
differ
consid
p
valu
everi
group
pread
drug
list
tabl
valu
two
prescript
efwdffbsrf
efbsrfsf
concentr
significantli
larger
correspond
viru
control
group
p
valu
prescript
efbsrf
gml
efsfwdffbsrf
gml
wdffbsrfsf
gml
efwdffsf
gml
efsf
efwdff
gml
significantli
larger
correspond
viru
control
group
p
valu
flavon
ingredi
ef
bsrf
sf
concentr
wdff
gml
group
also
significantli
larger
correspond
viru
control
group
p
valu
ef
gml
group
prescript
efbsrf
gml
group
tabl
valu
everi
group
pread
drug
n
efsfwdffbsrf
gml
group
significantli
larger
correspond
viru
control
group
p
also
significantli
larger
correspond
cell
control
group
p
highest
viru
inhibitori
rate
illustr
tabl
highest
viru
inhibitori
rate
ef
highest
next
one
efsfwdffbsrf
top
five
rate
high
low
pread
drug
mode
ef
efsfwdffbsrf
efwdffsf
efbsrf
wdffbsrfsf
turn
valu
everi
group
postad
drug
list
tabl
valu
nine
prescript
except
efwdffsf
gml
four
flavon
ingredi
except
sf
gml
concentr
significantli
larger
correspond
viru
control
group
p
valu
flavon
ingredi
ef
bsrf
gml
group
prescript
efwdff
wdffbsrfsf
efsfwdffbsrf
concentr
efwdff
gml
group
efwdffbsrf
gml
group
efwdffsf
gml
group
wdffbsrf
gml
group
significantli
larger
correspond
viru
control
group
p
also
significantli
larger
correspond
cell
control
group
p
top
five
rate
high
low
postad
drug
mode
efsfwdffbsrf
efbsrf
wdffbsrfsf
efwdffsf
efwdffbsrf
turn
highest
viru
inhibitori
rate
efsfwdffbsrf
highest
tabl
valu
everi
group
simultaneousad
drug
viru
mode
list
tabl
valu
five
prescript
wdffbsrf
efbsrf
wdffbsrfsf
efwdffbsrf
efsfwdffbsrf
four
flavon
ingredi
concentr
significantli
larger
correspond
viru
control
group
p
valu
flavon
ingredi
bsrf
gml
group
prescript
efbsrf
efsfwdffbsrf
gml
group
efwdffbsrf
gml
group
significantli
larger
correspond
viru
control
group
p
also
significantli
larger
correspond
cell
control
group
p
top
five
rate
high
low
simultaneousad
drug
viru
mode
efbsrf
efwdffbsrf
bsrf
efsfwdffbsrf
efwdff
turn
highest
viru
inhibitori
rate
efbsrf
highest
tabl
score
rank
antivir
activ
flavon
ingredi
prescript
list
tabl
top
two
total
score
high
low
respect
efsfwdffbsrf
efbsrf
next
efwdffbsrf
total
score
three
prescript
larger
other
total
score
sf
efsf
lowest
compar
within
differ
ad
drug
mode
score
ef
sf
efwdffsf
wdffbsrfsf
pread
drug
mode
larger
ad
drug
mode
score
bsrf
wdffbsrf
efwdffbsrf
simultaneousad
viru
drug
larger
ad
drug
mode
howev
score
prescript
efsfwdffbsrf
efbsrf
three
ad
drug
mode
approach
present
front
row
antibodi
titer
everi
group
illustr
fig
vaccin
day
first
vaccin
signific
differ
among
titer
five
group
p
day
first
vaccin
antibodi
titer
bc
group
significantli
lower
four
group
p
vc
group
significantli
lower
three
flavon
prescript
group
except
efwdffbsrf
group
p
day
first
vaccin
signific
differ
among
titer
three
flavon
prescript
group
p
day
first
vaccin
antibodi
titer
efsfwdffbsrf
group
higher
tabl
highest
viru
inhibit
rate
drug
three
drugad
mode
two
flavon
prescript
group
p
day
challeng
higher
efwdffbsrf
group
p
significantli
higher
efbsrf
group
p
result
morbid
mortal
protect
rate
immun
protect
test
list
tabl
mortal
morbid
three
flavon
prescript
group
lower
vc
group
efsfwdffbsrf
group
lowest
significantli
lower
vc
group
p
signific
differ
morbid
mortal
among
three
flavon
prescript
group
p
protect
rate
three
flavon
prescript
group
higher
vc
group
efsfwdffbsrf
group
highest
significantli
higher
vc
group
p
higher
two
flavon
prescript
group
p
cell
absorb
valu
valu
index
reflect
number
live
cell
relat
cell
growth
larger
valu
live
cell
experi
vitro
tabl
valu
everi
group
postad
drug
n
note
ae
data
within
column
without
superscript
differ
significantli
p
valu
everi
group
simultaneousad
drug
viru
n
note
ad
data
within
column
without
superscript
differ
significantli
p
score
rank
antivir
activ
flavon
ingredi
prescript
tabl
morbid
mortal
protect
rate
immun
protect
test
design
three
drugad
mode
respect
correspond
prevent
steril
treatment
three
clinic
administr
present
experi
valu
nine
prescript
concentr
postand
simultaneousad
mode
prescript
proper
dose
pread
mode
significantli
higher
correspond
viru
control
group
result
suggest
prescript
could
effect
inhibit
ndv
infect
vitro
steril
treatment
effect
better
prevent
effect
viru
inhibitori
rate
directli
reflect
antivir
intens
drug
score
rank
antivir
activ
benefit
compar
antivir
activ
three
drugad
mode
prescript
efsfwdffbsrf
efbsrf
efwdffbsrf
present
top
five
highest
viru
inhibitori
rate
furthermor
total
score
locat
highest
three
score
rank
moreov
valu
prescript
efsfwdffbsrf
pre
post
simultaneousad
efbsrf
pre
simultaneousad
efwdffbsrf
post
simultaneousad
significantli
larger
correspond
viru
control
group
p
also
significantli
larger
correspond
cell
control
group
p
result
suggest
prescript
efsfwdffbsrf
efbsrf
efwdffbsrf
possess
best
antivir
effect
inhibit
cellular
infect
ndv
vitro
prescript
flavon
ingredi
thu
three
prescript
efsfwdffbsrf
efbsrf
efwdffbsrf
chosen
object
medicin
vivo
experi
order
valid
whether
antivir
effect
prescript
vitro
vivo
consist
experi
vivo
design
humor
immun
mediat
b
lymphocyt
one
main
factor
resist
infecti
diseas
import
specif
immun
respons
peripher
antibodi
level
poultri
marker
reflect
humor
immun
function
bird
speci
play
import
role
host
defens
infecti
diseas
antibodi
titer
higher
infect
degre
chicken
ndv
less
seriou
result
immun
protect
test
show
day
first
vaccin
day
challeng
antibodi
titer
three
flavon
prescript
group
especi
essfwdffbsrf
group
significantli
higher
vc
group
bc
group
confirm
three
flavon
prescript
could
acceler
antibodi
product
vaccin
challeng
chicken
efficaci
essfwdffbsrf
stronger
two
prescript
result
consist
antivir
effect
prescript
vitro
confirm
three
flavon
prescript
especi
essfwdffbsrf
best
efficaci
enhanc
humor
immun
thu
improv
immun
effect
nd
vaccin
effect
chines
herbal
medicin
enhanc
immun
function
probabl
due
direct
action
immun
system
indirect
effect
system
sinc
three
flavon
prescript
could
improv
immun
effect
nd
vaccin
challeng
test
design
evalu
immun
protect
effect
infect
ndv
result
show
essfwdffbsrf
group
mortal
mortal
lowest
protect
rate
highest
prove
essfwdffbsrf
possess
best
immun
protect
effect
infect
nd
result
vitro
vivo
consist
experi
chicken
vaccin
nd
vaccin
challeng
therefor
challeng
time
select
day
first
vaccin
averag
titer
matern
antibodi
vc
group
ndv
use
challeng
virul
strain
lethal
dose
difficult
control
though
mortal
experiment
chicken
low
side
experiment
data
could
still
distinguish
protect
effect
group
antivir
effect
singl
flavon
prescript
compar
three
ad
drug
mode
highest
viru
inhibitori
rate
ef
highest
pread
drug
mode
thu
pread
drug
mode
combin
singl
flavon
weaken
antivir
effect
ef
efsfwdffbsrf
possess
highest
viru
inhibitori
rate
nine
prescript
highest
viru
inhibitori
rate
wdffbsrf
lower
indic
mutual
inhibit
wdff
bsrf
howev
mutual
inhibit
weaken
sf
ef
ad
wdffbsrf
prescript
reason
highest
viru
inhibitori
rate
efwdffbsrf
wdffbsrfsf
efsfwdffbsrf
locat
front
rank
highest
viru
inhibitori
rate
prescript
efsfwdffbsrf
efbsrf
present
highest
rank
postand
simultaneousad
mode
result
suggest
combin
four
ingredi
ef
sf
wdff
bsrf
two
ingredi
ef
bsrf
two
foresaid
mode
show
synergist
effect
addit
combin
efbsrf
efwdffbsrf
wdffbsrfsf
postad
drug
efwdffbsrf
simultaneousad
viru
drug
demonstr
effect
howev
simultaneousad
mode
combin
efwdffsf
wdffbsrfsf
show
significantli
mutual
inhibit
word
antivir
effect
chines
herbal
ingredi
intim
correl
compat
drug
also
mode
action
say
prescript
could
emerg
differ
biolog
activ
differ
mode
action
also
demonstr
antindv
mode
chines
herbal
flavon
ingredi
prescript
multilink
yan
tan
also
confirm
antivir
effect
chines
herbal
flavon
ingredi
relat
directli
kill
viru
inhibit
procedur
viru
replic
activ
strengthen
immun
therefor
could
exert
antivir
efficaci
differ
way
gener
speak
complic
mechan
compat
tradit
chines
herbal
medicin
bioactiv
synergist
effect
mutual
inhibit
need
studi
compat
theori
tradit
chines
medicin
prescript
valuabl
refer
purpos
conclus
flavon
prescript
compos
suitabl
compat
could
possess
synergist
action
antivir
effect
vitro
vivo
essfwdffbsrf
prescript
could
significantli
inhibit
cellular
infect
ndv
improv
protect
effect
nd
vaccin
chicken
would
expect
exploit
newtyp
antivir
drug
immunopotenti
